| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.35B | 36.41B | 31.55B | 25.46B | 20.89B | 0.00 |
| Gross Profit | 5.92B | 36.41B | 6.20B | 25.46B | 20.89B | -98.00M |
| EBITDA | 8.68B | 8.67B | 7.83B | 5.66B | 5.16B | 5.01B |
| Net Income | 4.60B | 4.65B | 4.61B | 3.99B | 2.94B | 2.38B |
Balance Sheet | ||||||
| Total Assets | 191.02B | 184.99B | 125.27B | 101.99B | 81.80B | 68.16B |
| Cash, Cash Equivalents and Short-Term Investments | 109.76B | 91.88B | 21.15B | 14.86B | 11.43B | 8.05B |
| Total Debt | 80.64B | 65.62B | 53.41B | 41.33B | 28.69B | 23.91B |
| Total Liabilities | 167.50B | 166.04B | 109.92B | 88.58B | 71.99B | 60.87B |
| Stockholders Equity | 23.50B | 18.92B | 15.31B | 13.38B | 9.71B | 7.21B |
Cash Flow | ||||||
| Free Cash Flow | -8.93B | -9.17B | 2.10B | -2.60B | 789.00M | 110.00M |
| Operating Cash Flow | -8.35B | -7.76B | 2.49B | -449.00M | 1.61B | 1.32B |
| Investing Cash Flow | -1.76B | -2.46B | -3.09B | -2.32B | -1.03B | -1.17B |
| Financing Cash Flow | 35.24B | 6.22B | 6.89B | 6.18B | 2.80B | 1.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥78.47B | 21.69 | ― | 2.02% | 13.52% | 7.75% | |
81 Outperform | ¥25.44B | 17.71 | ― | 2.50% | 16.70% | 22.23% | |
72 Outperform | ¥3.25B | 3.97 | ― | 2.04% | 12.86% | -63.06% | |
69 Neutral | ¥445.37B | 16.35 | 14.42% | 4.80% | 10.39% | 12.77% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | ¥41.08B | 20.82 | ― | ― | 13.25% | 1251.39% | |
56 Neutral | ¥72.37B | 12.85 | ― | 2.44% | 15.20% | -16.02% |